CURA_1170x120_8-22-19

Auvi-Q 0.1 mg

Kaleo to launch Auvi-Q auto-injector for young children

Kaleo to launch Auvi-Q auto-injector for young children

RICHMOND, Va. — Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.1 mg, which can be used to treat life-threatening allergic reactions, including anaphylaxis,